Views & Analysis AI is the future - but is that future now? The latest ‘big tech’ wave is getting many in the healthcare industry excited.
Views & Analysis The first decade of biosimilars – and beyond Sandoz’s CEO Richard Francis on the latest developments in biosimilars.
Articles Patientcentricity: is pharma making progress? 8 insights fr... Pharma is moving towards greater patientcentricity – but there are plenty of obstacles and commercial pressures remaining, reports Andrew McConaghie.
News PBM reform dropped in Congress' funding package Proposed reforms to the regulations for PBMs were dropped from the US Congress' end-of-year bill to provide funding to the federal government.
Digital Sponsored The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
